首页 >
法规速递
-
Page: Type-IB variations: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Worksharing: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Grouping of variations: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Pre-authorisation guidance-2026/3/27
2026-03-30查看详情 > -
Page: Type-IA variations: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Extensions of marketing authorisations: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Biosimilar medicines: Overview-2026/3/27
2026-03-30查看详情 > -
Page: Reflection paper on a tailored clinical approach in biosimilar development-2026/3/27
2026-03-30查看详情 > -
Page: Post-authorisation efficacy studies: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Type-II variations: questions and answers-2026/3/27
2026-03-30查看详情 >
